Azar’s IPI: socialist or capitalist?

The Trump administration’s plan for an international reference pricing scheme for Medicare Part B drugs has provoked vituperative opposition from BIO, PhRMA and their allies who have branded it as an attempt to impose socialism.

Others see the opposite side of the coin. The proposal for an International Pricing Index (IPI) has received qualified support from unexpected quarters, including Avik Roy, a prominent free-market advocate who says a tweaked version of the scheme would inject a healthy dose of capitalism into a flawed government-controlled payment system...